Endometrial intraepithelial neoplasia clinical correlates and outcomes

Obstetrics and Gynecology

Volumn 118, Issue 1, 2011, Pages 21-28

  Semere, Luwam G ^a   Ko, Emily ^a   Johnson, Natasha R ^a   Vitonis, Allison F ^a   Phang, Laura J ^a   Cramer, Daniel W ^a   Mutter, George L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER GROWTH; CANCER RISK; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA IN SITU; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 79959634160     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31821d78af     Document Type: Article

References (16)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al (editors). SEER cancer statistics review, 1975-2005. Bethesda (MD): National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2008/. Retrieved May 11, 2011.
2. Mutter GL, Matias-Guiu X, Lax SF. Endometrial Adenocarcinoma. In: Robbboy SJ, Mutter GL, Prat J, Bentley RC, Russell P, Anderson MC, editors. Robboy's pathology of the female reproductive tract. 2nd ed. New York (NY): Elsevier; 2009. p. 393-426.
3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-7. (Pubitemid 13194678)
4. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol 2005; 18:324-30. (Pubitemid 40395349)
5. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol 2000;19:301-9.
6. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 2000;76:287-90. (Pubitemid 30131494)
7. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 2005;103:2304-12. (Pubitemid 40686575)
8. Mutter GL, Zaino RJ, Baak JP, Bentley RC, Robboy SJ. The benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 2007;26: 103-14. (Pubitemid 46573204)
9. Mutter GL, Kauderer J, Baak JP, Alberts D, Gynecologic Oncology Group. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study. Hum Pathol 2008;39:866-74.
10. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812-9. (Pubitemid 43238448)
11. Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergstrom R, Lindgren A, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 1999;91:1131-7. (Pubitemid 29330551)
12. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41: 1-16.
13. Signorelli M, Caspani G, Bonazzi C, Chiappa V, Perego P, Mangioni C. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. BJOG 2009; 116:114-8.
14. Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, et al. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia-a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol 2008;139:169-75.
15. Wheeler DT, Bristow RE, Kurman RJ. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 2007;31:988-98. (Pubitemid 47012294)
16. Lin MC, Lomo L, Baak JPA, Eng C, Ince TA, Crum CP, et al. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Path 2009;22: 167-74.